Orthofix Medical Inc
OFIX15.480USD
+0.540+3.61%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
611.20MMarket Cap
LossP/E TTM
More Details of Orthofix Medical Inc Company
Orthofix Medical Inc. is a global medical technology company. Its Global Spine segment offers two product categories: Bone Growth Therapies and Spinal Implants, Biologics, and Enabling Technologies. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures. This segment specializes in the design, development, and marketing of external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. Spinal Implants, Biologics, and Enabling Technologies includes a portfolio of spine fixation and motion preservation implant products used in surgical procedures of the spine.
Company Info
Ticker SymbolOFIX
Company nameOrthofix Medical Inc
IPO dateApr 24, 1992
CEOMr. Massimo Calafiore
Number of employees1616
Security typeOrdinary Share
Fiscal year-endApr 24
Address3451 Plano Pkwy
CityLEWISVILLE
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code75056-9453
Phone12149372000
Websitehttps://ir.orthofix.com/ir-home/default.aspx
Ticker SymbolOFIX
IPO dateApr 24, 1992
CEOMr. Massimo Calafiore
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Jason M. Hannon
Mr. Jason M. Hannon
Independent Director
Independent Director
69.64K
+37.09%
Mr. Michael M. Finegan
Mr. Michael M. Finegan
Independent Chairman of the Board
Independent Chairman of the Board
55.80K
+87.78%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
54.07K
+53.48%
Mr. Charles R. (Chuck) Kummeth
Mr. Charles R. (Chuck) Kummeth
Independent Director
Independent Director
43.29K
+77.08%
Mr. Massimo Calafiore
Mr. Massimo Calafiore
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.09K
+33.23%
Mr. Patrick G. Fisher
Mr. Patrick G. Fisher
President - Global Orthopedics
President - Global Orthopedics
28.05K
-6.64%
Mr. Max Reinhardt
Mr. Max Reinhardt
President - Global Spine
President - Global Spine
3.16K
-34.23%
Ms. Julie B. Andrews
Ms. Julie B. Andrews
Chief Financial Officer
Chief Financial Officer
--
--
Mr. John Bell (Jack) Henneman, III
Mr. John Bell (Jack) Henneman, III
Independent Director
Independent Director
--
--
Mr. Wayne C. Burris
Mr. Wayne C. Burris
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Jason M. Hannon
Mr. Jason M. Hannon
Independent Director
Independent Director
69.64K
+37.09%
Mr. Michael M. Finegan
Mr. Michael M. Finegan
Independent Chairman of the Board
Independent Chairman of the Board
55.80K
+87.78%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
54.07K
+53.48%
Mr. Charles R. (Chuck) Kummeth
Mr. Charles R. (Chuck) Kummeth
Independent Director
Independent Director
43.29K
+77.08%
Mr. Massimo Calafiore
Mr. Massimo Calafiore
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.09K
+33.23%
Mr. Patrick G. Fisher
Mr. Patrick G. Fisher
President - Global Orthopedics
President - Global Orthopedics
28.05K
-6.64%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Spinal Implants
108.79M
56.18%
Bone Growth Therapies
55.05M
28.43%
By RegionUSD
Name
Revenue
Proportion
United States
161.68M
83.49%
International
31.96M
16.51%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Spinal Implants
108.79M
56.18%
Bone Growth Therapies
55.05M
28.43%
Shareholding Stats
Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Engine Capital Management, LP
10.77%
Rubric Capital Management LP
9.42%
Paradigm Capital Management, Inc.
8.46%
Armistice Capital LLC
7.54%
BlackRock Institutional Trust Company, N.A.
7.26%
Other
56.56%
Shareholders
Shareholders
Proportion
Engine Capital Management, LP
10.77%
Rubric Capital Management LP
9.42%
Paradigm Capital Management, Inc.
8.46%
Armistice Capital LLC
7.54%
BlackRock Institutional Trust Company, N.A.
7.26%
Other
56.56%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
41.97%
Hedge Fund
24.84%
Investment Advisor
21.10%
Research Firm
3.06%
Individual Investor
2.44%
Pension Fund
0.53%
Bank and Trust
0.32%
Insurance Company
0.04%
Other
5.70%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
383
34.24M
86.73%
-7.53M
2025Q1
400
36.08M
92.22%
-6.00M
2024Q4
406
35.79M
91.88%
-7.42M
2024Q3
405
37.21M
98.94%
-7.35M
2024Q2
405
38.09M
101.30%
-7.13M
2024Q1
403
37.91M
101.53%
-6.95M
2023Q4
403
37.82M
103.01%
-4.07M
2023Q3
385
35.80M
97.80%
-3.46M
2023Q2
374
34.87M
95.30%
-3.10M
2023Q1
386
34.87M
101.51%
+7.31M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Engine Capital Management, LP
4.25M
10.85%
+510.28K
+13.64%
May 07, 2025
Rubric Capital Management LP
3.69M
9.43%
--
--
Mar 31, 2025
Paradigm Capital Management, Inc.
2.48M
6.33%
-4.20K
-0.17%
Mar 31, 2025
Armistice Capital LLC
2.96M
7.56%
-36.00K
-1.20%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.76M
7.04%
+3.76K
+0.14%
Mar 31, 2025
Juniper Investment Company, LLC
2.39M
6.09%
+249.13K
+11.66%
Apr 09, 2025
The Vanguard Group, Inc.
2.17M
5.54%
+54.53K
+2.58%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
812.27K
2.07%
+152.79K
+23.17%
Mar 31, 2025
State Street Global Advisors (US)
860.34K
2.2%
-24.51K
-2.77%
Mar 31, 2025
AYAL Capital Advisors Limited
539.77K
1.38%
-101.00
-0.02%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Sep 6
Updated: Sat, Sep 6
Name
Proportion
Innovator US Small Cap Managed Floor ETF
0%
Dimensional US Core Equity 1 ETF
0%
VictoryShares Small Cap Free Cash Flow ETF
0%
DFA Dimensional US Small Cap Value ETF
0%
iShares Core S&P Small-Cap ETF
0%
SPDR S&P SmallCap 600 ESG ETF
0%
SPDR Portfolio S&P 1500 Composite Stock Market ETF
0%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0%
SPDR S&P 600 Small Cap Value ETF
0%
iShares ESG Select Screened S&P Small-Cap ETF
0%
View more
Innovator US Small Cap Managed Floor ETF
Proportion0%
Dimensional US Core Equity 1 ETF
Proportion0%
VictoryShares Small Cap Free Cash Flow ETF
Proportion0%
DFA Dimensional US Small Cap Value ETF
Proportion0%
iShares Core S&P Small-Cap ETF
Proportion0%
SPDR S&P SmallCap 600 ESG ETF
Proportion0%
SPDR Portfolio S&P 1500 Composite Stock Market ETF
Proportion0%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
Proportion0%
SPDR S&P 600 Small Cap Value ETF
Proportion0%
iShares ESG Select Screened S&P Small-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
